查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1954299

避孕市场分析及至2035年预测：依类型、产品、服务、技术、应用、剂型、材料类型及最终用户划分

Contraceptives Market Analysis and Forecast to 2035: Type, Product, Services, Technology, Application, Form, Material Type, End User
出版日期: | 出版商: Global Insight Services | 英文 354 Pages | 商品交期: 3-5个工作天内

价格
简介目录

预计避孕市场规模将从2024年的336亿美元成长到2034年的564亿美元，年复合成长率约为5.1%。避孕市场涵盖用于预防怀孕的产品和方法，包括荷尔蒙避孕药、保险套、子宫内避孕器和节育手术。推动该市场成长的因素包括计划生育意识的提高、政府措施以及避孕方法技术的进步。对长效可逆避孕方法（LARC）的需求不断增长以及对女性健康的日益关注，正在推动创新，以确保避孕方法的有效性和安全性。

避孕市场正经历强劲成长，这主要得益于人们对计划生育和生殖健康解决方案的日益重视和需求成长。口服避孕药市场表现突出，其中复方口服避孕药和仅含孕激素的口服避孕药因其有效性和易用性而广受欢迎。注射避孕药紧随其后，反映出其在寻求无需每日註射的长期避孕方案的女性中越来越受欢迎。避孕植入的需求也在上升，它能提供长期保护和便利性。男性避孕市场目前尚不成熟，但随着研发投入的增加，其成长潜力也活性化。非荷尔蒙避孕方法，例如铜子宫内避孕器，正受到寻求无荷尔蒙替代方案族群的青睐。用于生育追踪和避孕管理的数位健康应用程式正在成为促进用户参与和持续使用的重要工具。整体而言，随着技术进步和研发投入的增加推动创新和普及，市场可望进一步扩张。

市场区隔
类型 荷尔蒙、屏障避孕法、避孕器避孕器、节育手术、自然避孕法
产品 保险套、口服避孕药、注射避孕针、植入避孕器、子宫内避孕器（IUD）、事后紧急避孕药、阴道环、避孕贴片、杀精剂
服务 计划生育服务、咨询服务和教育服务
科技 长效可逆避孕法（LARC）、短效荷尔蒙避孕法、永久性避孕方法
目的 预防和治疗
形式 口服、注射、外用、植入式
材料类型 乳胶、非乳胶、聚氨酯
最终用户 医院、诊所和居家医疗

避孕药具市场的特征是市占率分布动态变化、定价策略竞争激烈、创新产品层出不穷。在消费者意识不断提高和社会对计划生育态度转变的推动下，该行业正经历强劲增长。各公司正加大研发投入，推出满足消费者多元需求的先进避孕解决方案。定价策略竞争激烈，主要企业利用规模经济优势提供高性价比的选择。旨在拓展产品系列和增强市场渗透率的策略联盟和伙伴关係也进一步支持了市场发展。避孕药具市场的竞争异常激烈，主要企业力求透过创新和品牌定位来实现差异化。区域法规结构对市场动态有显着影响，严格的指导方针确保了产品的安全性和有效性。儘管市场由少数主要企业主导，但新参与企业也正在取得显着进展。北美和欧洲的监管机构持续制定严格的标准，影响产品核可时间和打入市场策略。技术进步和对个人化避孕需求的不断增长预计将推动市场持续成长。

主要趋势和驱动因素：

避孕市场正经历强劲成长，这主要得益于人们对计划生育和生殖健康的认识和需求不断提高。政府主导的各项措施和日益增长的宣传活动正在推广避孕措施的使用，提高不同族群的避孕可及性和认知度。包括长效可逆避孕方法（LARCs）在内的创新避孕技术应运而生，以满足消费者对便利性和有效性的不断变化的偏好。此外，随着越来越多的女性寻求对自身生育选择拥有更大的掌控权，人们对女性健康和赋权的日益重视也促使避孕器的使用率不断提高。市场正朝着非荷尔蒙避孕方式转变，这反映了消费者对更安全、更天然的替代方案的需求。此外，远端医疗和数位健康平台的扩展也促进了人们获得避孕产品和咨询服务，尤其是在偏远地区。在新兴经济体，不断加快的都市化和生活方式的改变正在推动对避孕解决方案的需求，这为市场带来了巨大的机会。专注于提供价格合理、易于取得的避孕产品的公司将占据有利地位，从而获得可观的市场份额。此外，与医疗机构和非政府组织建立合作关係可以加强分销网络和推广工作，确保更多人获得避孕选择。在技​​术进步和全球对生殖健康与权利日益关注的推动下，预计该市场将持续成长。

目录

第一章执行摘要

第二章 市集亮点

第三章 市场动态

  • 宏观经济分析
  • 市场趋势
  • 市场驱动因素
  • 市场机会
  • 市场限制
  • 复合年均成长率：成长分析
  • 影响分析
  • 新兴市场
  • 技术蓝图
  • 战略框架

第四章 细分市场分析

  • 市场规模及预测：依类型
    • 荷尔蒙
    • 屏障法
    • 子宫内避孕器
    • 节育手术
    • 自然法
  • 市场规模及预测：依产品划分
    • 保险套
    • 口服避孕药
    • 注射
    • 植入
    • 子宫内避孕器（IUD）
    • 事后紧急避孕药
    • 阴道环
    • 修补
    • 杀精剂
  • 市场规模及预测：依服务划分
    • 计划生育服务
    • 咨询服务
    • 教育服务
  • 市场规模及预测：依技术划分
    • 长效可逆避孕法（LARC）
    • 短效荷尔蒙避孕药
    • 永久避孕
  • 市场规模及预测：依应用领域划分
    • 预防
    • 治疗
  • 市场规模及预测：依类型
    • 口服
    • 注射
    • 外用
    • 嵌入式
  • 市场规模及预测：依材料类型划分
    • 乳胶
    • 非乳胶
    • 聚氨酯
  • 市场规模及预测：依最终用户划分
    • 医院
    • 诊所
    • 居家医疗

第五章 区域分析

  • 北美洲
    • 我们
    • 加拿大
    • 墨西哥
  • 拉丁美洲
    • 巴西
    • 阿根廷
    • 其他拉丁美洲地区
  • 亚太地区
    • 中国
    • 印度
    • 韩国
    • 日本
    • 澳洲
    • 台湾
    • 亚太其他地区
  • 欧洲
    • 德国
    • 法国
    • 英国
    • 西班牙
    • 义大利
    • 其他欧洲地区
  • 中东和非洲
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 南非
    • 撒哈拉以南非洲
    • 其他中东和非洲地区

第六章 市场策略

  • 需求与供给差距分析
  • 贸易和物流限制
  • 价格、成本和利润率趋势
  • 市场渗透率
  • 消费者分析
  • 法规概述

第七章 竞争讯息

  • 市场定位
  • 市场占有率
  • 竞争基准
  • 主要企业的策略

第八章 公司简介

  • Reckitt Benckiser Group
  • Church & Dwight
  • Mayer Laboratories
  • Mankind Pharma
  • Cupid Limited
  • Fuji Latex Co Ltd
  • HLL Lifecare Limited
  • Veru Inc
  • Okamoto Industries
  • Ansell Limited
  • Sagami Rubber Industries
  • Karex Berhad
  • Thai Nippon Rubber Industry
  • Bio Film Inc
  • Shanghai Dahua Medical Apparatus
  • Sir Richard's Condom Company
  • RFSU AB
  • Caya
  • Bexen Medical
  • Lelo

第九章：关于我们

简介目录
Product Code: GIS32245

Contraceptives Market is anticipated to expand from $33.6 billion in 2024 to $56.4 billion by 2034, growing at a CAGR of approximately 5.1%. The Contraceptives Market encompasses products and methods used to prevent pregnancy, including hormonal pills, condoms, intrauterine devices, and sterilization procedures. This market is driven by increasing awareness of family planning, government initiatives, and technological advancements in contraceptive methods. Rising demand for long-acting reversible contraceptives and the growing emphasis on women's health are fueling innovations, ensuring both efficacy and safety.

The Contraceptives Market is experiencing robust growth, driven by increasing awareness and demand for family planning and reproductive health solutions. The oral contraceptives segment leads in performance, with combination pills and progestin-only pills being widely preferred due to their effectiveness and ease of use. The injectable contraceptives segment follows closely, reflecting rising popularity among women seeking long-term solutions without daily administration. The demand for contraceptive implants is also on the rise, offering prolonged protection and convenience. The male contraceptives segment, though currently underdeveloped, shows potential for growth as research and development efforts intensify. Non-hormonal contraceptives, such as copper IUDs, are gaining traction among individuals seeking hormone-free alternatives. Digital health applications for fertility tracking and contraceptive management are emerging as valuable tools, enhancing user engagement and adherence. Overall, the market is poised for expansion, with technological advancements and increasing investments in research and development driving innovation and accessibility.

Market Segmentation
TypeHormonal, Barrier, Intrauterine, Sterilization, Natural
ProductCondoms, Oral Contraceptive Pills, Injectables, Implants, Intrauterine Devices (IUDs), Emergency Contraceptives, Vaginal Rings, Patches, Spermicides
ServicesFamily Planning Services, Counseling Services, Educational Services
TechnologyLong-acting Reversible Contraceptives (LARC), Short-acting Hormonal Methods, Permanent Methods
ApplicationPreventive, Therapeutic
FormOral, Injectable, Topical, Implantable
Material TypeLatex, Non-Latex, Polyurethane
End UserHospitals, Clinics, Homecare

The contraceptives market is characterized by a dynamic landscape of market share distribution, competitive pricing strategies, and a surge in innovative product launches. The sector is witnessing robust growth, fueled by increased consumer awareness and evolving societal attitudes towards family planning. Companies are intensifying their efforts in research and development to introduce advanced contraceptive solutions, catering to diverse consumer needs. Pricing strategies remain competitive, with key players leveraging economies of scale to offer cost-effective options. The market is further buoyed by strategic collaborations and partnerships aimed at expanding product portfolios and enhancing market penetration. Competition within the contraceptives market is intense, with major players striving to differentiate through innovation and brand positioning. Regulatory frameworks across various regions significantly influence market dynamics, with stringent guidelines ensuring product safety and efficacy. The landscape is shaped by a few dominant players, yet new entrants are making notable inroads. Regulatory bodies in North America and Europe continue to set stringent standards, impacting product approval timelines and market entry strategies. The market is poised for sustained growth, driven by technological advancements and increasing demand for personalized contraceptive options.

Geographical Overview:

The contraceptives market is witnessing varied growth dynamics across different regions, with emerging opportunities in several countries. North America remains a dominant player, driven by increased awareness and the availability of advanced contraceptive methods. The region's robust healthcare infrastructure supports market expansion. Europe also demonstrates strong growth, buoyed by government initiatives promoting family planning and reproductive health. Asia Pacific is a burgeoning market, with rapid urbanization and rising disposable incomes contributing to increased demand for contraceptives. Countries like India and China are at the forefront, with significant investments in healthcare and education. Latin America is emerging as a promising market, with Brazil and Mexico leading due to progressive health policies and improved access to contraceptives. In the Middle East & Africa, there is a growing recognition of the importance of reproductive health, with countries like South Africa and Nigeria showing potential. Efforts to improve healthcare access and education are key drivers in these regions.

Global tariffs and geopolitical tensions are significantly influencing the contraceptives market, particularly in East Asia. Japan and South Korea are navigating these challenges by diversifying suppliers and investing in domestic pharmaceutical innovation to mitigate tariff impacts. China is focusing on self-reliance, enhancing its manufacturing capabilities to reduce dependency on international imports. Taiwan, a key player in pharmaceutical components, faces geopolitical risks that could disrupt supply chains. The global contraceptives market is experiencing steady growth, driven by increasing awareness and demand for reproductive health products. By 2035, the market is anticipated to evolve with advanced product offerings and improved accessibility. Middle East conflicts contribute to volatile energy prices, indirectly affecting manufacturing and distribution costs across the pharmaceutical industry, including contraceptives.

Key Trends and Drivers:

The contraceptives market is experiencing robust growth fueled by rising awareness and demand for family planning and reproductive health. Increasing government initiatives and educational campaigns are promoting the use of contraceptives, enhancing accessibility and awareness among diverse populations. The emergence of innovative contraceptive technologies, including long-acting reversible contraceptives, is catering to the evolving preferences of consumers seeking convenience and efficacy. Moreover, the growing emphasis on women's health and empowerment is driving the adoption of contraceptives, as women seek greater control over their reproductive choices. The market is witnessing a shift towards non-hormonal contraceptive options, reflecting consumer demand for safer and more natural alternatives. In addition, the expansion of telemedicine and digital health platforms is facilitating easier access to contraceptive products and consultations, particularly in remote areas. Opportunities abound in emerging economies where increasing urbanization and changing lifestyles are driving demand for contraceptive solutions. Companies that focus on affordability and accessibility are well-positioned to capture significant market share. Furthermore, partnerships with healthcare providers and NGOs can enhance distribution networks and outreach efforts, ensuring broader access to contraceptive options. The market's trajectory is poised for continuous growth, supported by technological advancements and a global focus on reproductive health and rights.

Research Scope:

  • Estimates and forecasts the overall market size across type, application, and region.
  • Provides detailed information and key takeaways on qualitative and quantitative trends, dynamics, business framework, competitive landscape, and company profiling.
  • Identifies factors influencing market growth and challenges, opportunities, drivers, and restraints.
  • Identifies factors that could limit company participation in international markets to help calibrate market share expectations and growth rates.
  • Evaluates key development strategies like acquisitions, product launches, mergers, collaborations, business expansions, agreements, partnerships, and R&D activities.
  • Analyzes smaller market segments strategically, focusing on their potential, growth patterns, and impact on the overall market.
  • Outlines the competitive landscape, assessing business and corporate strategies to monitor and dissect competitive advancements.

Our research scope provides comprehensive market data, insights, and analysis across a variety of critical areas. We cover Local Market Analysis, assessing consumer demographics, purchasing behaviors, and market size within specific regions to identify growth opportunities. Our Local Competition Review offers a detailed evaluation of competitors, including their strengths, weaknesses, and market positioning. We also conduct Local Regulatory Reviews to ensure businesses comply with relevant laws and regulations. Industry Analysis provides an in-depth look at market dynamics, key players, and trends. Additionally, we offer Cross-Segmental Analysis to identify synergies between different market segments, as well as Production-Consumption and Demand-Supply Analysis to optimize supply chain efficiency. Our Import-Export Analysis helps businesses navigate global trade environments by evaluating trade flows and policies. These insights empower clients to make informed strategic decisions, mitigate risks, and capitalize on market opportunities.

TABLE OF CONTENTS

1 Executive Summary

  • 1.1 Market Size and Forecast
  • 1.2 Market Overview
  • 1.3 Market Snapshot
  • 1.4 Regional Snapshot
  • 1.5 Strategic Recommendations
  • 1.6 Analyst Notes

2 Market Highlights

  • 2.1 Key Market Highlights by Type
  • 2.2 Key Market Highlights by Product
  • 2.3 Key Market Highlights by Services
  • 2.4 Key Market Highlights by Technology
  • 2.5 Key Market Highlights by Application
  • 2.6 Key Market Highlights by Form
  • 2.7 Key Market Highlights by Material Type
  • 2.8 Key Market Highlights by End User

3 Market Dynamics

  • 3.1 Macroeconomic Analysis
  • 3.2 Market Trends
  • 3.3 Market Drivers
  • 3.4 Market Opportunities
  • 3.5 Market Restraints
  • 3.6 CAGR Growth Analysis
  • 3.7 Impact Analysis
  • 3.8 Emerging Markets
  • 3.9 Technology Roadmap
  • 3.10 Strategic Frameworks
    • 3.10.1 PORTER's 5 Forces Model
    • 3.10.2 ANSOFF Matrix
    • 3.10.3 4P's Model
    • 3.10.4 PESTEL Analysis

4 Segment Analysis

  • 4.1 Market Size & Forecast by Type (2020-2035)
    • 4.1.1 Hormonal
    • 4.1.2 Barrier
    • 4.1.3 Intrauterine
    • 4.1.4 Sterilization
    • 4.1.5 Natural
  • 4.2 Market Size & Forecast by Product (2020-2035)
    • 4.2.1 Condoms
    • 4.2.2 Oral Contraceptive Pills
    • 4.2.3 Injectables
    • 4.2.4 Implants
    • 4.2.5 Intrauterine Devices (IUDs)
    • 4.2.6 Emergency Contraceptives
    • 4.2.7 Vaginal Rings
    • 4.2.8 Patches
    • 4.2.9 Spermicides
  • 4.3 Market Size & Forecast by Services (2020-2035)
    • 4.3.1 Family Planning Services
    • 4.3.2 Counseling Services
    • 4.3.3 Educational Services
  • 4.4 Market Size & Forecast by Technology (2020-2035)
    • 4.4.1 Long-acting Reversible Contraceptives (LARC)
    • 4.4.2 Short-acting Hormonal Methods
    • 4.4.3 Permanent Methods
  • 4.5 Market Size & Forecast by Application (2020-2035)
    • 4.5.1 Preventive
    • 4.5.2 Therapeutic
  • 4.6 Market Size & Forecast by Form (2020-2035)
    • 4.6.1 Oral
    • 4.6.2 Injectable
    • 4.6.3 Topical
    • 4.6.4 Implantable
  • 4.7 Market Size & Forecast by Material Type (2020-2035)
    • 4.7.1 Latex
    • 4.7.2 Non-Latex
    • 4.7.3 Polyurethane
  • 4.8 Market Size & Forecast by End User (2020-2035)
    • 4.8.1 Hospitals
    • 4.8.2 Clinics
    • 4.8.3 Homecare

5 Regional Analysis

  • 5.1 Global Market Overview
  • 5.2 North America Market Size (2020-2035)
    • 5.2.1 United States
      • 5.2.1.1 Type
      • 5.2.1.2 Product
      • 5.2.1.3 Services
      • 5.2.1.4 Technology
      • 5.2.1.5 Application
      • 5.2.1.6 Form
      • 5.2.1.7 Material Type
      • 5.2.1.8 End User
    • 5.2.2 Canada
      • 5.2.2.1 Type
      • 5.2.2.2 Product
      • 5.2.2.3 Services
      • 5.2.2.4 Technology
      • 5.2.2.5 Application
      • 5.2.2.6 Form
      • 5.2.2.7 Material Type
      • 5.2.2.8 End User
    • 5.2.3 Mexico
      • 5.2.3.1 Type
      • 5.2.3.2 Product
      • 5.2.3.3 Services
      • 5.2.3.4 Technology
      • 5.2.3.5 Application
      • 5.2.3.6 Form
      • 5.2.3.7 Material Type
      • 5.2.3.8 End User
  • 5.3 Latin America Market Size (2020-2035)
    • 5.3.1 Brazil
      • 5.3.1.1 Type
      • 5.3.1.2 Product
      • 5.3.1.3 Services
      • 5.3.1.4 Technology
      • 5.3.1.5 Application
      • 5.3.1.6 Form
      • 5.3.1.7 Material Type
      • 5.3.1.8 End User
    • 5.3.2 Argentina
      • 5.3.2.1 Type
      • 5.3.2.2 Product
      • 5.3.2.3 Services
      • 5.3.2.4 Technology
      • 5.3.2.5 Application
      • 5.3.2.6 Form
      • 5.3.2.7 Material Type
      • 5.3.2.8 End User
    • 5.3.3 Rest of Latin America
      • 5.3.3.1 Type
      • 5.3.3.2 Product
      • 5.3.3.3 Services
      • 5.3.3.4 Technology
      • 5.3.3.5 Application
      • 5.3.3.6 Form
      • 5.3.3.7 Material Type
      • 5.3.3.8 End User
  • 5.4 Asia-Pacific Market Size (2020-2035)
    • 5.4.1 China
      • 5.4.1.1 Type
      • 5.4.1.2 Product
      • 5.4.1.3 Services
      • 5.4.1.4 Technology
      • 5.4.1.5 Application
      • 5.4.1.6 Form
      • 5.4.1.7 Material Type
      • 5.4.1.8 End User
    • 5.4.2 India
      • 5.4.2.1 Type
      • 5.4.2.2 Product
      • 5.4.2.3 Services
      • 5.4.2.4 Technology
      • 5.4.2.5 Application
      • 5.4.2.6 Form
      • 5.4.2.7 Material Type
      • 5.4.2.8 End User
    • 5.4.3 South Korea
      • 5.4.3.1 Type
      • 5.4.3.2 Product
      • 5.4.3.3 Services
      • 5.4.3.4 Technology
      • 5.4.3.5 Application
      • 5.4.3.6 Form
      • 5.4.3.7 Material Type
      • 5.4.3.8 End User
    • 5.4.4 Japan
      • 5.4.4.1 Type
      • 5.4.4.2 Product
      • 5.4.4.3 Services
      • 5.4.4.4 Technology
      • 5.4.4.5 Application
      • 5.4.4.6 Form
      • 5.4.4.7 Material Type
      • 5.4.4.8 End User
    • 5.4.5 Australia
      • 5.4.5.1 Type
      • 5.4.5.2 Product
      • 5.4.5.3 Services
      • 5.4.5.4 Technology
      • 5.4.5.5 Application
      • 5.4.5.6 Form
      • 5.4.5.7 Material Type
      • 5.4.5.8 End User
    • 5.4.6 Taiwan
      • 5.4.6.1 Type
      • 5.4.6.2 Product
      • 5.4.6.3 Services
      • 5.4.6.4 Technology
      • 5.4.6.5 Application
      • 5.4.6.6 Form
      • 5.4.6.7 Material Type
      • 5.4.6.8 End User
    • 5.4.7 Rest of APAC
      • 5.4.7.1 Type
      • 5.4.7.2 Product
      • 5.4.7.3 Services
      • 5.4.7.4 Technology
      • 5.4.7.5 Application
      • 5.4.7.6 Form
      • 5.4.7.7 Material Type
      • 5.4.7.8 End User
  • 5.5 Europe Market Size (2020-2035)
    • 5.5.1 Germany
      • 5.5.1.1 Type
      • 5.5.1.2 Product
      • 5.5.1.3 Services
      • 5.5.1.4 Technology
      • 5.5.1.5 Application
      • 5.5.1.6 Form
      • 5.5.1.7 Material Type
      • 5.5.1.8 End User
    • 5.5.2 France
      • 5.5.2.1 Type
      • 5.5.2.2 Product
      • 5.5.2.3 Services
      • 5.5.2.4 Technology
      • 5.5.2.5 Application
      • 5.5.2.6 Form
      • 5.5.2.7 Material Type
      • 5.5.2.8 End User
    • 5.5.3 United Kingdom
      • 5.5.3.1 Type
      • 5.5.3.2 Product
      • 5.5.3.3 Services
      • 5.5.3.4 Technology
      • 5.5.3.5 Application
      • 5.5.3.6 Form
      • 5.5.3.7 Material Type
      • 5.5.3.8 End User
    • 5.5.4 Spain
      • 5.5.4.1 Type
      • 5.5.4.2 Product
      • 5.5.4.3 Services
      • 5.5.4.4 Technology
      • 5.5.4.5 Application
      • 5.5.4.6 Form
      • 5.5.4.7 Material Type
      • 5.5.4.8 End User
    • 5.5.5 Italy
      • 5.5.5.1 Type
      • 5.5.5.2 Product
      • 5.5.5.3 Services
      • 5.5.5.4 Technology
      • 5.5.5.5 Application
      • 5.5.5.6 Form
      • 5.5.5.7 Material Type
      • 5.5.5.8 End User
    • 5.5.6 Rest of Europe
      • 5.5.6.1 Type
      • 5.5.6.2 Product
      • 5.5.6.3 Services
      • 5.5.6.4 Technology
      • 5.5.6.5 Application
      • 5.5.6.6 Form
      • 5.5.6.7 Material Type
      • 5.5.6.8 End User
  • 5.6 Middle East & Africa Market Size (2020-2035)
    • 5.6.1 Saudi Arabia
      • 5.6.1.1 Type
      • 5.6.1.2 Product
      • 5.6.1.3 Services
      • 5.6.1.4 Technology
      • 5.6.1.5 Application
      • 5.6.1.6 Form
      • 5.6.1.7 Material Type
      • 5.6.1.8 End User
    • 5.6.2 United Arab Emirates
      • 5.6.2.1 Type
      • 5.6.2.2 Product
      • 5.6.2.3 Services
      • 5.6.2.4 Technology
      • 5.6.2.5 Application
      • 5.6.2.6 Form
      • 5.6.2.7 Material Type
      • 5.6.2.8 End User
    • 5.6.3 South Africa
      • 5.6.3.1 Type
      • 5.6.3.2 Product
      • 5.6.3.3 Services
      • 5.6.3.4 Technology
      • 5.6.3.5 Application
      • 5.6.3.6 Form
      • 5.6.3.7 Material Type
      • 5.6.3.8 End User
    • 5.6.4 Sub-Saharan Africa
      • 5.6.4.1 Type
      • 5.6.4.2 Product
      • 5.6.4.3 Services
      • 5.6.4.4 Technology
      • 5.6.4.5 Application
      • 5.6.4.6 Form
      • 5.6.4.7 Material Type
      • 5.6.4.8 End User
    • 5.6.5 Rest of MEA
      • 5.6.5.1 Type
      • 5.6.5.2 Product
      • 5.6.5.3 Services
      • 5.6.5.4 Technology
      • 5.6.5.5 Application
      • 5.6.5.6 Form
      • 5.6.5.7 Material Type
      • 5.6.5.8 End User

6 Market Strategy

  • 6.1 Demand-Supply Gap Analysis
  • 6.2 Trade & Logistics Constraints
  • 6.3 Price-Cost-Margin Trends
  • 6.4 Market Penetration
  • 6.5 Consumer Analysis
  • 6.6 Regulatory Snapshot

7 Competitive Intelligence

  • 7.1 Market Positioning
  • 7.2 Market Share
  • 7.3 Competition Benchmarking
  • 7.4 Top Company Strategies

8 Company Profiles

  • 8.1 Reckitt Benckiser Group
    • 8.1.1 Overview
    • 8.1.2 Product Summary
    • 8.1.3 Financial Performance
    • 8.1.4 SWOT Analysis
  • 8.2 Church & Dwight
    • 8.2.1 Overview
    • 8.2.2 Product Summary
    • 8.2.3 Financial Performance
    • 8.2.4 SWOT Analysis
  • 8.3 Mayer Laboratories
    • 8.3.1 Overview
    • 8.3.2 Product Summary
    • 8.3.3 Financial Performance
    • 8.3.4 SWOT Analysis
  • 8.4 Mankind Pharma
    • 8.4.1 Overview
    • 8.4.2 Product Summary
    • 8.4.3 Financial Performance
    • 8.4.4 SWOT Analysis
  • 8.5 Cupid Limited
    • 8.5.1 Overview
    • 8.5.2 Product Summary
    • 8.5.3 Financial Performance
    • 8.5.4 SWOT Analysis
  • 8.6 Fuji Latex Co Ltd
    • 8.6.1 Overview
    • 8.6.2 Product Summary
    • 8.6.3 Financial Performance
    • 8.6.4 SWOT Analysis
  • 8.7 HLL Lifecare Limited
    • 8.7.1 Overview
    • 8.7.2 Product Summary
    • 8.7.3 Financial Performance
    • 8.7.4 SWOT Analysis
  • 8.8 Veru Inc
    • 8.8.1 Overview
    • 8.8.2 Product Summary
    • 8.8.3 Financial Performance
    • 8.8.4 SWOT Analysis
  • 8.9 Okamoto Industries
    • 8.9.1 Overview
    • 8.9.2 Product Summary
    • 8.9.3 Financial Performance
    • 8.9.4 SWOT Analysis
  • 8.10 Ansell Limited
    • 8.10.1 Overview
    • 8.10.2 Product Summary
    • 8.10.3 Financial Performance
    • 8.10.4 SWOT Analysis
  • 8.11 Sagami Rubber Industries
    • 8.11.1 Overview
    • 8.11.2 Product Summary
    • 8.11.3 Financial Performance
    • 8.11.4 SWOT Analysis
  • 8.12 Karex Berhad
    • 8.12.1 Overview
    • 8.12.2 Product Summary
    • 8.12.3 Financial Performance
    • 8.12.4 SWOT Analysis
  • 8.13 Thai Nippon Rubber Industry
    • 8.13.1 Overview
    • 8.13.2 Product Summary
    • 8.13.3 Financial Performance
    • 8.13.4 SWOT Analysis
  • 8.14 Bio Film Inc
    • 8.14.1 Overview
    • 8.14.2 Product Summary
    • 8.14.3 Financial Performance
    • 8.14.4 SWOT Analysis
  • 8.15 Shanghai Dahua Medical Apparatus
    • 8.15.1 Overview
    • 8.15.2 Product Summary
    • 8.15.3 Financial Performance
    • 8.15.4 SWOT Analysis
  • 8.16 Sir Richard's Condom Company
    • 8.16.1 Overview
    • 8.16.2 Product Summary
    • 8.16.3 Financial Performance
    • 8.16.4 SWOT Analysis
  • 8.17 RFSU AB
    • 8.17.1 Overview
    • 8.17.2 Product Summary
    • 8.17.3 Financial Performance
    • 8.17.4 SWOT Analysis
  • 8.18 Caya
    • 8.18.1 Overview
    • 8.18.2 Product Summary
    • 8.18.3 Financial Performance
    • 8.18.4 SWOT Analysis
  • 8.19 Bexen Medical
    • 8.19.1 Overview
    • 8.19.2 Product Summary
    • 8.19.3 Financial Performance
    • 8.19.4 SWOT Analysis
  • 8.20 Lelo
    • 8.20.1 Overview
    • 8.20.2 Product Summary
    • 8.20.3 Financial Performance
    • 8.20.4 SWOT Analysis

9 About Us

  • 9.1 About Us
  • 9.2 Research Methodology
  • 9.3 Research Workflow
  • 9.4 Consulting Services
  • 9.5 Our Clients
  • 9.6 Client Testimonials
  • 9.7 Contact Us